| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/12/2013 | WO2013016352A8 Recombinant virus products and methods for inhibition of expression of dux4 |
| 09/12/2013 | WO2012068470A3 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 09/12/2013 | US20130237696 Vascular therapeutics |
| 09/12/2013 | US20130237594 Split dose administration |
| 09/12/2013 | US20130237588 Vascular therapeutics |
| 09/12/2013 | US20130236964 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 09/12/2013 | US20130236510 Multiplexed supramolecular assemblies for non-viral delivery of genetic material |
| 09/11/2013 | EP2636746A1 A novel drug delivery system based on JCV-VLP |
| 09/11/2013 | EP2636742A1 Induction of exon skipping in eukaryotic cells |
| 09/11/2013 | EP2636741A1 Induction of exon skipping in eukaryotic cells |
| 09/11/2013 | EP2636740A1 Induction of exon skipping in eukaryotic cells |
| 09/11/2013 | EP2636739A1 iRNA agents targeting VEGF |
| 09/11/2013 | EP2636737A1 Skin and hair color-controlling factor |
| 09/11/2013 | EP2636735A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
| 09/11/2013 | EP2636678A1 Derivatives of small interfering rnas and use thereof |
| 09/11/2013 | EP2635707A1 Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease |
| 09/11/2013 | EP2635308A2 Compositions of a peptide targeting system for treating cancer |
| 09/11/2013 | EP2635261A2 Compositions and methods for nanopolymer-based nucleic acid delivery |
| 09/11/2013 | CN103298936A Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
| 09/11/2013 | CN103298928A Method for activating helper t cell |
| 09/11/2013 | CN103298485A Multivalent vaccine for filariasis |
| 09/11/2013 | CN103298475A Design of oligonucleotide analogs as therapeutic agents |
| 09/11/2013 | CN103290112A Application of CCDC158 gene in preparation of liver cancer treatment or diagnosis medicament |
| 09/11/2013 | CN103290101A Ago2 gene and application of expression product thereof |
| 09/11/2013 | CN103290049A Small-ring type DNA (deoxyribonucleic acid) recombinant vector for blocking HIV (human immunodeficiency virus)-1 membrane fusion and application thereof |
| 09/11/2013 | CN103290029A Survivin promoter mediated recombinant vector for expressing Gelonin phytotoxin genes and usage thereof |
| 09/11/2013 | CN103290018A Nucleic acid aptamer specifically bound with human epidermal growth factor receptor III-type mutant and application of nucleic acid aptamer |
| 09/11/2013 | CN103288966A Fusion receptor and gene medicine thereof for treating colorectal cancer |
| 09/11/2013 | CN103288934A Haemophilus parasuis immunoprotective antigen HbpA |
| 09/11/2013 | CN103288933A Haemophilus parasuis immunoprotective antigen CdtC |
| 09/11/2013 | CN103285407A Preparation method of polyamide-amine type dendritic macromolecule-entrapped miR-21 gene inhibitor |
| 09/11/2013 | CN103285406A MicroRNA-203, and application of analogue thereof in preparation of medicament for preventing and treating obesity, dyslipidemia and complication of obesity and dyslipidemia |
| 09/11/2013 | CN103285405A Gene medicine for promoting differentiation of tumor stem cells and applications thereof |
| 09/11/2013 | CN103285404A Regulating function of miR-290 family in mouse embryonic stem cell |
| 09/11/2013 | CN102628047B Nucleic acid aptamer rich in guanine and application thereof |
| 09/11/2013 | CN102628046B Nucleic acid aptamer rich in guanine |
| 09/11/2013 | CN102586327B D24 fiber protein modified conditionally replicating adenovirus carrier with exogenous gene by one-step method and application of carrier |
| 09/11/2013 | CN102140464B Human miR-1238 antisense nucleic acid and applications thereof |
| 09/11/2013 | CN101559241B Hyaluronic acid-hydroxyapatite nano composite sphere and preparation method |
| 09/11/2013 | CN101280293B Urate oxidase |
| 09/10/2013 | US8530636 Method for regulating protein function in cells in vivo using synthetic small molecules |
| 09/10/2013 | US8530443 miR-150 for the treatment of blood disorders |
| 09/10/2013 | US8530442 Modified CEA nucleic acid and expression vectors |
| 09/10/2013 | US8530441 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
| 09/10/2013 | US8530439 Modulation of apolipoprotein C-III expression |
| 09/10/2013 | US8530438 Vivo production of small interfering RNAs that mediate gene silencing |
| 09/10/2013 | US8530436 Methods and compositions for transdermal delivery of nucleotides |
| 09/10/2013 | US8530234 Hepatitis C virus vaccine |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8530214 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 09/10/2013 | US8530149 Dermal micro-organs, methods and apparatuses for producing and using the same |
| 09/10/2013 | US8529939 Purified protein(s) combined with drug(s) and biocompatible solvent(s) to form a coatable mixture; reduction to form a cohesive body or solidified cohesive mass that is formed into a mucoadhesive device havinghomogenous distribution; ovalbumin combined with glycerol; bonding strength |
| 09/10/2013 | US8529906 Compositions for inducing immune responses |
| 09/10/2013 | US8529905 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/10/2013 | US8529904 Antigenic peptide comprising sequenc simimlarity to wilm's tumor-1 gene a nd gata-1 transcription factor for use as targeting tools in treatment of cell proliferative disorders; tissue targeted therapy |
| 09/10/2013 | US8529885 AAV vectors for in vivo gene therapy of rheumatoid arthritis |
| 09/10/2013 | US8529884 Using vector transformation to express herpes simple-1 viral gene sequences in cells; inducing immune response to pathogen attack |
| 09/10/2013 | CA2610919C Hepatitis c virus nucleic acid vaccine |
| 09/10/2013 | CA2595894C Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment |
| 09/10/2013 | CA2529056C Combinations of tumor-associated antigens in compositions for various types of cancers |
| 09/10/2013 | CA2513398C Antisense oligonucleotides that inhibit expression of hif-1 |
| 09/10/2013 | CA2456247C Use of il-18 inhibitors in hypersensitivity disorders |
| 09/10/2013 | CA2427340C Cyp1b1 nucleic acids and methods of use |
| 09/06/2013 | WO2013130393A1 Aav-directed persistent expression of an anti-nicotine antibody gene for smoking cessation |
| 09/06/2013 | WO2013128022A1 Method for preventing or treating a hepatitis c virus infection or a hepatitis b virus infection by administration of suicide gene-modified lymphocytes |
| 09/06/2013 | WO2013127964A1 Retroviral transduction using poloxamers |
| 09/06/2013 | WO2013126963A1 Pain treatment |
| 09/06/2013 | WO2013100818A3 A biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, a method of making the biocomposite and a method of treating inquiries. |
| 09/05/2013 | US20130231266 METHODS AND COMPOSITIONS REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 09/05/2013 | US20130230920 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
| 09/05/2013 | US20130230902 Chimeric adenoviruses for use in cancer treatment |
| 09/05/2013 | US20130230595 Methods of Using Multilayer Magnetic Micelle Compositions |
| 09/05/2013 | US20130230504 Peptide antagonists of vascular endothelial growth factor and methods of use thereof |
| 09/04/2013 | EP2634253A1 Adeno-associated virus virions for transferring genes into neural cells |
| 09/04/2013 | EP2633051A1 Hbv treatment |
| 09/04/2013 | EP2633034A2 NFkB SIGNAL PATH-MANIPULATED DENDRITIC CELLS |
| 09/04/2013 | CN1622995B Receptor nucleic acids and polypeptides |
| 09/04/2013 | CN103282503A Small molecule conjugates for intracellular delivery of nucleic acids |
| 09/04/2013 | CN103282502A Small molecule conjugates for intracellular delivery of biologically active compounds |
| 09/04/2013 | CN103276015A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/04/2013 | CN103275984A MCP-1 binding nucleic acids |
| 09/04/2013 | CN103275982A Long non-coding RNA (Ribonucleic Acid) and applications thereof |
| 09/04/2013 | CN103275971A RNA interference targets for hepatitis b virus (HBV) infection treatment |
| 09/04/2013 | CN103275329A PEG modified polyethylene imine derivative and preparation method thereof |
| 09/04/2013 | CN103275269A Phosphoryl choline polymer containing aldehyde group and preparation method and application thereof |
| 09/04/2013 | CN103275227A AXL antibodies |
| 09/04/2013 | CN103272248A Application of miR-15b in preparing diabetes diagnosis and treatment preparation |
| 09/04/2013 | CN103272247A MLDH (Magnetic Layered Double Hydroxide)-DNA (Deoxyribose Nucleic Acid) supramolecular assembly type gene magnetic targeting transport system |
| 09/04/2013 | CN103272233A Application of MLL (mixed lineage leukemia) 1 antibody and expression inhibiter in preparing medicine for treating AML (acute myeloid leukemia) |
| 09/04/2013 | CN103272228A Biological control method of crucian hemorrhagic disease and application thereof |
| 09/04/2013 | CN102657875B ANT1 gene-based targeted immunoliposome, preparation method thereof and application thereof |
| 09/04/2013 | CN102600080B Enzymatic type cleavable PEGylation ( polyethylene glycol) lipid material |
| 09/04/2013 | CN101918035B Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent |
| 09/04/2013 | CN101269214B EG-VEGF nucleotide and using method |
| 09/03/2013 | US8524881 Reduction of off-target RNA interference toxicity |
| 09/03/2013 | US8524879 RNA interference suppresion of neurodegenerative diseases and methods of use thereof |
| 09/03/2013 | US8524872 Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer |
| 09/03/2013 | US8524871 Modified gherlin peptides |
| 09/03/2013 | US8524684 Antisense antiviral compounds and methods for treating a filovirus infection |
| 09/03/2013 | US8524679 In vivo delivery of double stranded RNA to a target cell |